Abstract
Acute limb ischemia occurs from an abrupt interruption of blood flow to an extremity, usually because of embolic or thrombotic vascular occlusion. It can also result from trauma and dissection. With an embolic occlusion, a cardiac origin is the source of emboli in 80–90 % of cases, usually in the setting of atrial fibrillation/flutter or acute myocardial infarction (O’Connell and Quiñones-Baldrich, Semin Vasc Surg. 22(1):10–16, 2009). The presence of rheumatic or prosthetic cardiac valves, endocarditis, and cardiac tumors (such as left atrial myxoma) is also associated with increased risk of embolic events. Furthermore, paradoxical embolism of venous thrombi through an intra-atrial communication (such as an atrial septal defect (ASD) or patent foramen ovale (PFO)), or less commonly an intraventricular communication, is also encountered in some patients. Hence, this chapter discusses cardiac causes of limb ischemia including dissection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Am Coll Cardiol. 2006;47(6):1239–312.
Falluji N, Mukherjee D. Critical and acute limb ischemia: an overview. Angiology. 2014;65(2):137–46.
Walker TG. Acute limb Ischemia. Tech Vasc Interv Rad 12:117–29.
O’Connell JB, Quiñones-Baldrich WJ. Proper evaluation and management of acute embolic versus thrombotic limb ischemia. Semin Vasc Surg. 2009;22(1):10–6.
Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 114(7): e257–354.
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004;110:1042.
Frost L1, Engholm G, Johnsen S, Møller H, Henneberg EW, Husted S. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med. 2001;161:272–6.
Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010;105(4):502–10.
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72.
January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;28. pii: S0735-1097(14)01740-9.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42.
Asinger RW, Mikell FL, Elsperger J, Hodges M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med. 1981;305(6):297–302.
Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23):1743–9.
Chiarella F, Santoro E, Domenicucci S, Maggioni A, Vecchio C. Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol. 1998;81(7):822–7.
Gianstefani S, Douiri A, Delithanasis I, Rogers T, Sen A, Kalra S, et al. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention. Am J Cardiol. 2014;113(7):1111–6.
Küpper AJ, Verheugt FW, Peels CH, Galema TW, Roos JP. Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol. 1989;13(7):1514–20.
Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987;75:1004.
Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolization. Ann Intern Med. 1986;104(5):689–98.
Delewi R1, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23):1743–49.
Cabin HS, Roberts WC. Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease. Chest. 1980;77(5):586–90.
Nixon JV. Left ventricular mural thrombus. Arch Intern Med. 1983;143(8):1567–71.
Jugdutt BI1, Sivaram CA. Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction. J Am Coll Cardiol. 1989;13(3):554–64.
Weinstein L, Schlesinger JJ. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (second of two parts). N Engl J Med. 1974;291(21):1122–6.
Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394–434.
Vilacosta I, Graupner C, San Román JA, Sarriá C, Ronderos R, Fernández C, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39(9):1489–95.
Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14(3):631–8.
Prendergast BD1, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121(9):1141–52.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.
Molina JE, Edwards JE, Ward HB. Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg. 1990;38 Suppl 2:183.
Tazelaar HD, Locke TJ, McGregor CG. Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc. 1992;67(10):957.
Odim J, Reehal V, Laks H, Mehta U, Fishbein MC. Surgical pathology of cardiac tumors. Two decades at an urban institution. Cardiovasc Pathol. 2003;12(5):267.
Livi U, Bortolotti U, Milano A, Valente M, Prandi A, Frugoni C, et al. Cardiac myxomas: results of 14 years’ experience. Thorac Cardiovasc Surg. 1984;32(3):143–7.
Reynen K. Cardiac myxomas. N Engl J Med. 1995;333(24):1610–7.
Coley C, Lee KR, Steiner M, Thompson CS. Complete embolization of a left atrial myxoma resulting in acute lower extremity ischemia. Tex Heart Inst J. 2005;32(2):238–40.
Chiba K, Abe H, Kitanaka Y, Makuuchi H. Left atrial myxoma complicated with an acute upper extremity embolism. Ann Thorac Cardiovasc Surg. 2012;18(4):391–4.
Bhan A, Mehrotra R, Choudhary SK, Sharma R, Prabhakar D, Airan B. Surgical experience with intracardiac myxomas: long-term follow-up. Ann Thorac Surg. 1998;66(3):810–3.
Edwards FH, Hale D, Cohen A, Thompson L, Pezzella AT, Virmani R. Primary cardiac valve tumors. Ann Thorac Surg. 1991;52(5):1127–31.
Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404.
Sun JP, Asher CR, Yang XS, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103:2687–93.
Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol. 1997;30:784–90.
Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613–23.
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20.
Hugl B, Klein-Weigel P, Posch L, Greiner A, Fraedrich G. Peripheral ischemia caused by paradoxical embolization: an underestimated problem? Mt Sinai J Med. 2005;72(3):200–6.
Miller S, Causey MW, Schachter D, Andersen CA, Singh N. A case of limb ischemia secondary to paradoxical embolism. Vasc Endovascular Surg. 2010;44(7):604–8.
Chen WJ, Kuan P, Lien WP, Lin FY. Detection of patent foramen ovale by contrast transesophageal echocardiography. Chest. 1992;101(6):1515–20.
Tobis J, Shenoda M. Percutaneous treatment of patent foramen ovale and atrial septal defects. J Am Coll Cardiol. 2012;60(18):1722–32.
Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–9.
Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6:147.
Vales L, Kanei Y, Ephrem G, Misra D. Intra-aortic balloon pump use and outcomes with current therapies. J Invasive Cardiol. 2011;23(3):116–9.
Kantrowitz A, Wasfie T, Freed PS, Rubenfire M, Wajszczuk W, Schork MA. Intraaortic balloon pumping 1967 through 1982: analysis of complications in 733 patients. Am J Cardiol. 1986;57(11):976–83.
Alderman JD, Gabliani GI, McCabe CH, Brewer CC, Lorell BH, Pasternak RC, et al. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol. 1987;9(3):524–30.
Al-Attar N, Roussel A, Khaliel F. Extracorporeal membrane oxygenation (ECMO). ESC Council Cardiol Pract. 2013;11(22).
Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15(3):172–8.
Taglieri N1, Galiè N, Marzocchi A. Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. J Invasive Cardiol. 2013;25(2):89–91.
Rose SH. Ischemic complications of radial artery cannulation: an association with a calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia variant of scleroderma. Anesthesiology. 1993;78(3):587–9.
Mangar D1, Laborde RS, Vu DN. Delayed ischaemia of the hand necessitating amputation after radial artery cannulation. Can J Anaesth. 1993;40(3):247–50.
Khakha RS, Ali T, Chong P, Gerrard D, Leopold P. Embolisation of Angio-Seal™ device: an unusual case of post-cardiac catheterisation limb ischaemia. Ann R Coll Surg Engl. 2011;93(5):e41–2.
Teso D, Karmy-Jones R. Distal embolism of percutaneous arterial closure device resulting in critical limb ischemia. J Vasc Interv Radiol. 2010;21(10):1487–8.
Hagan, P, Nienaber C, Isselbacher E, et al. The international registry of acute aortic dissection (IRAD) new insights into an old disease. JAMA. 2000;283(7):897–903.
Nusair M, Abuzetun J, Khaja A, Dohrmann M. A case of aortic dissection in a cocaine abuser: a case report and review of the literature. Cases J. 2008;1:369.
Fann JI, Sarris GE, Mitchell RS, Shumway NE, Stinson EB, Oyer PE, Miller DC. Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg. 1990;212(6):705–13.
Sutton MS, Oldershaw PJ, Miller GA, Paneth M, Williams B, Braimbridge M. Dissection of the thoracic aorta. A comparison between medical and surgical treatment. J Cardiovasc Surg (Torino). 1981;22(3):195–202.
Slater EE, DeSanctis RW. The clinical recognition of dissecting aortic aneurysm. Am J Med. 1976;60(5):625–33.
Cambria RP, Brewster DC, Gertler J, Moncure AC, Gusberg R, Tilson MD, et al. Vascular complications associated with spontaneous aortic dissection. J Vasc Surg. 1988;7(2):199–209.
Steingruber I, Chemelli A, Glodny B, Hugl B, Bonatti J, Hiemetzbeger R, Jaschke W, Czermak B. Endovascular repair of acute type B aortic dissections: midterm results. J Endovasc Ther. 2008;15(2):150–60.
Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest. 2002;122(1):311–28.
Patel AY, Eagle KA, Vaishnava P. Acute type B aortic dissection: insights from the international registry of acute aortic dissection. Ann Cardiothorac Surg. 2014;3(4):368–74.
Gargiulo M, Massoni CB, Gallitto E, Freyrie A, Trimarchi S, Faggioli G, Stella A. Lower limb malperfusion in type B aortic dissection: a systematic review. Ann Cardiothorac Surg. 2014;3(4):351–67.
Trimarchi S, Segreti S, Grassi V, Lomazzi C, Cova M, Piffaretti G, Rampoldi V. Open fenestration for complicated acute aortic B dissection. Ann Cardiothorac Surg. 2014;3(4):418–22.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Dieter, R.A., Overly, T.L., Roberts, M.A., Gallegos, J.J. (2017). Cardiac Causes of Acute and Chronic Limb Ischemia. In: Dieter, R., Dieter, Jr, R., Dieter, III, R., Nanjundappa, A. (eds) Critical Limb Ischemia. Springer, Cham. https://doi.org/10.1007/978-3-319-31991-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-31991-9_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31989-6
Online ISBN: 978-3-319-31991-9
eBook Packages: MedicineMedicine (R0)